Engineering CAR-T cells
Abstract Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. Afte...
Main Authors: | Cheng Zhang, Jun Liu, Jiang F. Zhong, Xi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-017-0102-y |
Similar Items
-
Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-09-01) -
Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-11-01) -
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01) -
Characterizing piggyBat—a transposase for genetic modification of T cells
by: Gaurav Sutrave, et al.
Published: (2022-06-01) -
The Past, Present, and Future of Non-Viral CAR T Cells
by: Alex Moretti, et al.
Published: (2022-06-01)